View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Market Data
November 24, 2016

Deals this week: EUROIMMUN (SEA), Konica Minolta Healthcare, Shockwave Medical

To enable better clinical management of patients with suspected allergies, diagnostic systems developer EUROIMMUN (SEA), has initiated a strategic partnership with Angsana Molecular & Diagnostics.

To enable better clinical management of patients with suspected allergies, diagnostic systems developer EUROIMMUN (SEA), has initiated a strategic partnership with Angsana Molecular & Diagnostics.

The companies will collaborate to work on allergy diagnostics and testing. While Angsana offers comprehensive analysis of sensitisations against inhalation, food and other allergens to enable precise determination of allergen, EUROIMMUN will work on customising two allergy profiles to suite and cater South East Asia.

Medical diagnostic imaging provider, Konica Minolta Healthcare, has entered a partnership with medical device producer, Mindray, to introduce exclusive musculoskeletal (MSK) portable ultrasound solutions.

"The companies will collaborate to work on allergy diagnostics and testing."

The collaboration, which combines Mindray’s patient care solutions with Konica’s cutting-edge technologies, will cater the need for advanced ultrasound technology in out-of-hospital settings and empower the MSK providers with best tools at the point of care.

In a series C venture financing round led by Sectoral Asset Management, medical device manufacturer, Shockwave Medical, has raised $45m, which will be used to advance the development of the company’s Lithoplasty balloon catheter platform and to expand the commercialisation of peripheral vascular disease treatment in the US and the EU.

The financing round has also seen the participation of a new investor named T. Rowe Price Associates and the company’s existing investors.

Related Companies

Free Report
img

VC funding trends to watch out for in Medical

The COVID-19 pandemic has exacerbated the need for digital health advancements as medicine shifts beyond conventional clinical-based patient care to more personalized and preventative models where digitalization is key.  There is an increasing interest in digital health as a paradigm for delivering treatment. The deal value in this segment totals $800mn.  GlobalData’s Venture Capital Investments – Medical 2021 will help you dive into the capital raising landscape across regions and themes.  Use the report to identify emerging signals and trends across Medical Devices, formulating winning strategies for the road ahead.   
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU